Navigation Links
Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2011 Financial Results on November 3, 2011
Date:10/27/2011

SAN DIEGO, Oct. 27, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced that it will release its third quarter ended September 30, 2011 financial results on Thursday, November 3, 2011.

Cadence management will host a conference call and live webcast to discuss the financial results on Thursday, November 3, 2011 at 1:30 pm Pacific Time (4:30 pm Eastern Time). Interested investors may participate in the conference call by dialing (877) 303-9145 (domestic) or (760) 536-5203 (international).  To access the webcast, please visit the company's website at www.cadencepharm.com and go to the Investor Relations page.  A replay of the webcast will be available approximately two hours after the call and remain available on the company's website until the next quarterly financial results call.

About Cadence Pharmaceuticals, Inc.Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. In January 2011, Cadence commercially launched OFIRMEV™ (acetaminophen) injection, an intravenous formulation of acetaminophen, in the U.S.  For more information about Cadence, please visit www.cadencepharm.com.Contacts:

William R. LaRueSVP & Chief Financial OfficerCadence Pharmaceuticals, Inc.858-436-1400
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cadence Pharmaceuticals to Present at Three Investment Conferences During the Month of September 2011
2. Cadence Pharmaceuticals Reports Second Quarter 2011 Financial Results
3. Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of August 2011
4. Cadence Pharmaceuticals Reaffirms FDA-Approved Dosing Recommendations for OFIRMEV® (acetaminophen) Injection
5. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Jefferies 2011 Global Healthcare Conference on June 9, 2011
6. Cadence, Inc. Announces Major Expansion
7. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2011 Financial Results on May 5, 2011
8. Cadence Pharmaceuticals CEO Ted Schroeder to Present at Three Investment Conferences During the Month of May 2011
9. Cadence, Inc. Expands Executive Team
10. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
11. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Cowen and Company 31st Annual Health Care Conference in Boston on March 9, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... -- Pharmavite LLC announced that Timothy "Tim" Toll has ... Toll recently served as Pharmavite,s executive vice president of ... label and sales administration in the United ... will expand his responsibilities to include international sales, global ... to chief customer officer is part of a plan ...
(Date:7/23/2014)... 23, 2014 /PRNewswire-iReach/ -- The Centers for Medicare & ... Innovation Network-Quality Improvement Organization (QIN-QIO) contract to a partnership ... Effective August 1, WVMI will launch Quality Insights ... , Pennsylvania , Delaware ... Louisiana.  The Network will engage providers and the community ...
(Date:7/23/2014)... /PRNewswire-iReach/ -- Use of Risk Evaluation and Mitigation Strategies ... market entry results in $5.4 billion in lost savings ... by economic consulting firm Matrix Global Advisors ... Required by the Food and Drug Administration ... are intended to improve drug safety by ensuring that ...
Breaking Medicine Technology:Announcing a New Regional Approach to Medicare Quality Improvement 2New Analysis Finds $5.4 Billion In Annual Lost Savings From Strategies Geared Toward Delaying Generic Drug Entry 2
... Texas, July 14, 2011 Convergen LifeSciences ... 7,977,468 has been awarded by the U.S. Patent and ... Board of Regents and The Secretary, U.S. Department of ... of 23 patents, pending or issued worldwide, licensed exclusively to ...
... REDWOOD CITY, Calif., July 14, 2011 Codexis, Inc. (Nasdaq: ... in the 13th Annual Pacific Crest Global Technology Leadership Forum, ... Robert Lawson, Senior Vice President and Chief Financial Officer, will ... Biofuels and Renewable Chemicals," scheduled for August 8 at 12:30 ...
Cached Medicine Technology:Convergen LifeSciences Announces Patent Award 2
(Date:7/23/2014)... Karen Pallarito HealthDay ... In a wild day for Obamacare, two federal appeals courts ... financial subsidies provided to millions of Americans who bought health ... suggest that the matter is headed for a showdown before ... morning, the U.S. Appeals Court for the District of Columbia ...
(Date:7/23/2014)... at the emergency department, the drug ketamine can ... life-saving intubation, despite decades-old studies that suggested it ... systematic review of 10 recent studies of what ... are published online in Annals of Emergency ... Intracranial and Cerebral Perfusion Pressure and Health Outcomes: ...
(Date:7/23/2014)... 2014 AidJoy is delighted to announce that ... Zen on September 5, 2014 from 7:00 to 11:00 ... are expected to attend this semi-formal event. , "We are ... past six years," says Jess Dennis, Director of Operations and ... on this moment in AidJoy’s history before we launch into ...
(Date:7/23/2014)... Dallas, Texas (PRWEB) July 23, 2014 ... to 2020?, provides key market data on the ... provides value, in millions of US dollars, and ... US dollars), within market categories Cardiac Valve Repairs ... company shares and distribution shares data for each ...
(Date:7/23/2014)... 23, 2014) Statins, a class of drugs commonly ... risk of developing Barrett,s esophagus, according to a new ... the official journal of the American Gastroenterological Association. Obese ... statin use. , "Patients who received statins had a ... esophagus compared to non-users," said study author Hashem B. ...
Breaking Medicine News(10 mins):Health News:2 Courts, 2 Different Decisions on Key Obamacare Provision 2Health News:2 Courts, 2 Different Decisions on Key Obamacare Provision 3Health News:Ketamine can be a wonder drug for ER patients and their physicians 2Health News:AidJoy’s Inaugural Gala to be Held September 5, 2014 2Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 2Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 3Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 4Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 5Health News:Statin use decreases the risk of Barrett's esophagus 2
... seriously ill adults who received care from a medical ... less likely to report medical errors, test duplication, and ... Fund international survey of patients, experiences in the U.S. ... Health Affairs "Web First" article, the study also ...
... 8 (HealthDay News) -- Astronauts who spend six months or ... the back of their eyes, causing their vision to become ... Researchers found these changes may be the result of prolonged ... Mars or other long-term manned space voyages. "In astronauts ...
... By Maureen Salamon HealthDay Reporter , ... coaxes the body to attack tumor cells has shown ... ovarian cancer patients, improving overall survival times and stopping ... The PANVAC vaccine, administered to 26 women through ...
... RICHMOND, Va. (Nov. 8, 2011) A team of Virginia ... 19-month-old conjoined twins Maria and Teresa Tapia of the Dominican ... 6 a.m. and was the first surgery of its kind ... David Lanning, M.D., Ph.D., associate professor in the VCU Department ...
... , TUESDAY, Nov. 8 (HealthDay News) -- The reversal ... of receiving a new organ from a deceased donor, U.S. ... Sharing (UNOS) gave priority to potential recipients who had a ... an antigen involved in the body,s immune response to foreign ...
... their opioid abuse when given sustained treatment with the ... in yesterday,s Archives of General Psychiatry and ... part of the National Institutes of Health. The study, ... using a medication for the treatment of prescription opioid ...
Cached Medicine News:Health News:New international health survey of sicker adults: Those with a medical home fare better 2Health News:New international health survey of sicker adults: Those with a medical home fare better 3Health News:New international health survey of sicker adults: Those with a medical home fare better 4Health News:New international health survey of sicker adults: Those with a medical home fare better 5Health News:Space Travel Might Lead to Eye Trouble: Study 2Health News:Vaccine to Treat Breast, Ovarian Cancers Shows Promise 2Health News:Vaccine to Treat Breast, Ovarian Cancers Shows Promise 3Health News:VCU performs separation surgery on conjoined twins 2Health News:VCU performs separation surgery on conjoined twins 3Health News:Racial Disparities Still Exist for Kidney Recipients, Study Finds 2Health News:Painkiller abuse treated by sustained buprenorphine/naloxone 2Health News:Painkiller abuse treated by sustained buprenorphine/naloxone 3
... contact lens cleaning solution is ... and professionally proven cleaner. A ... resulting in a very effective ... cosmetic residue, salts, mucous and ...
Round knurled handle. Overall length 130 mm....
Alvis foreign body spud 4 3/4 inches, oval curette 1 x 3 mm with fine point....
Foreign body spud angled, lightly rounded tip....
Medicine Products: